Variability among pediatric infectious diseases specialists in the treatment and prevention of methicillin-resistant Staphylococcus aureus skin and soft tissue infections.
There are currently no clear consensus recommendations for the treatment and prevention of community-associated methicillin-resistant Staphylococcus aureus skin and soft tissue infections in pediatric patients. We surveyed over 100 Pediatric Infectious Diseases consultants and found considerable variability in both the treatment of skin and soft tissue infections and the strategies used for the management of children with recurrent MRSA disease.
Creech
C Buddy
CB
Division of Pediatric Infectious Diseases, Department of Pediatrics, Vanderbilt University School of Medicine, Nashville, TN 37232, USA. buddy.creech@vanderbilt.edu
Beekmann
Susan E
SE
Chen
YiYi
Y
Polgreen
Philip M
PM
D017714:Community-Acquired Infections / Q000188:drug therapy / Q000382:microbiology / Q000517:prevention & control; D006296:Health Services / Q000592:standards*; D006801:Humans; D016106:Methicillin Resistance; D018461:Soft Tissue Infections / Q000188:drug therapy* / Q000382:microbiology / Q000517:prevention & control*; D013038:Specialization; D013203:Staphylococcal Infections / Q000188:drug therapy* / Q000382:microbiology / Q000517:prevention & control*; D013207:Staphylococcal Skin Infections / Q000188:drug therapy* / Q000382:microbiology / Q000517:prevention & control*; D013211:Staphylococcus aureus / Q000187:drug effects